Published 18 days ago • loading... • Updated 18 days ago

CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study

Summary by Medical Device Network

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH).The post CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study appeared first on Medical Device Network.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

Medical Device Network

CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study

18 days ago

Read Full Article

Endovascular Today

CereVasc’s eShunt Evaluated in Pilot Study of Elderly Patients With NPH - Endovascular Today

February 5, 2025—CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the treatment of elderly patients with normal pressure hydrocephalus (NPH). According to the company, the objective of the prospective, nonrandomized, open-label, multicenter study is to evaluate the safety and efficacy of the eShunt system procedure. The study is being conducted under an FDA-approved investiga…

18 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right